Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020 Johnson & Johnson Will Establish New U.S. Vaccine Manufacturing Capabilities and Additional Production Capacity Outside the

ADVANZ PHARMA to Acquire Correvio in a Deal Valued at US$76 MillionCorrevio to Hold a Meeting of Its Securityholders by No Later than May 20, 2020Transaction Expected to Close During the Second Quarter of 2020NASDAQ: CORV  TSX: CORV

PRINCETON, N.J., March 30, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the year ended

SUZHOU, China, March 30, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966HK) announced today that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab"), a wholly-owned subsidiary of the Company, has established strategic partnership with Simcere and 3D Medicines (Beijing) Co., Ltd. ("3DMed") to advance the d

FRISCO, Texas, March 30, 2020 /PRNewswire/ -- Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that the bank lending group to the Company's senior secured credit facility has consented to an extension of the timeline required to deliver the Company's December 31, 2019, audited financials and P

BLOOMFIELD, Conn., March 30, 2020 /PRNewswire/ -- Cigna is waiving customer cost-sharing and co-payments for COVID-19 treatment. This expanded coverage further protects Cigna customers and underscores the company's commitment to delivering access to simple, affordable and predictable health care.

MINNEAPOLIS, March 30, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced researchers from its Munich-based laboratory, Exosome Diagnostics, in a paper published in the scientific Journal of Extracellular Vesicles (JEV) (

INDIANAPOLIS, March 30, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for Taltz® (ixekizumab) injection, 80 mg/mL for the treatment of pediatric patients (ages 6 to under 18) with moderate to severe plaque psoriasis who are

LAUSANNE, Switzerland, March 30, 2020 /PRNewswire/ --

SEATTLE, March 30, 2020 /PRNewswire/ -- Altoura announced Monday it will give free licenses for its immersive VR/AR training and collaboration software for use in finding a COVID-19 vaccine or m